Emergent BioSolutions

AstraZeneca pledges $174M to ramp up coronavirus vaccine supply deal with Emergent
AstraZeneca pledges $174M to ramp up coronavirus vaccine supply deal with Emergent
Fierce Pharma
Emergent BioSolutions
vaccines
COVID-19
AstraZeneca
University of Oxford
Flag link:
J&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent
J&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent
Fierce Pharma
JNJ
CDMOs
Emergent BioSolutions
vaccines
COVID-19
drug manufacturing
Flag link:
AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine
AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine
Fierce Pharma
AstraZeneca
Emergent BioSolutions
COVID-19
vaccines
drug manufacturing
University of Oxford
Flag link:
US government promises Maryland drug manufacturer $628M to make coronavirus vaccines
US government promises Maryland drug manufacturer $628M to make coronavirus vaccines
BioPharma Dive
federal government
Emergent BioSolutions
vaccines
COVID-19
grants
Flag link:
Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal
Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal
Fierce Pharma
JNJ
vaccines
COVID-19
drug launches
CMOs
Emergent BioSolutions
Flag link:
Emergent BioSolutions Reports Mixed Results for Q4
Emergent BioSolutions Reports Mixed Results for Q4
Motley Fool
Emergent BioSolutions
earnings
Flag link:
Emergent BioSolutions Looks to Break $1 Billion
Emergent BioSolutions Looks to Break $1 Billion
Motley Fool
Emergent BioSolutions
earnings
Flag link:
Working for the government proves extremely profitable for Emergent
Working for the government proves extremely profitable for Emergent
EP Vantage
Emergent BioSolutions
Narcan
M&A
Adapt Pharma
Flag link:
Emergent BioSolutions to buy Narcan maker Adapt Pharma
Emergent BioSolutions to buy Narcan maker Adapt Pharma
Reuters
M&A
Emergent BioSolutions
Adapt Pharma
Narcan
Flag link:
Emergent BioSolutions Buys PaxVax for $270 Million
Emergent BioSolutions Buys PaxVax for $270 Million
BioSpace
M&A
Emergent BioSolutions
PaxVax
Flag link:
Emergent BioSolutions Acquires Sanofi's Smallpox Vaccine Unit
Emergent BioSolutions Acquires Sanofi's Smallpox Vaccine Unit
Yahoo/Zacks.com
Emergent BioSolutions
Sanofi
M&A
smallpox
vaccines
ACAM2000
Flag link:
Anthrax Vaccine Maker Emergent Hopes To Profit From Biotech Spinoff
Anthrax Vaccine Maker Emergent Hopes To Profit From Biotech Spinoff
Investors.com
anthrax
vaccines
Emergent BioSolutions
Aptevo
Flag link:
FDA approves Emergent BioSolutions' anthrax treatment
FDA approves Emergent BioSolutions' anthrax treatment
Yahoo/Reuters
FDA
Emergent BioSolutions
anthrax
Anthrasil
Flag link:
Ebola booster vaccine trial to combine GSK, Emergent Bio shots
Ebola booster vaccine trial to combine GSK, Emergent Bio shots
Yahoo/Reuters
ebola virus
vaccines
GSK
Emergent BioSolutions
Flag link:
Emergent's BioThrax Gets Orphan Drug Status
Emergent's BioThrax Gets Orphan Drug Status
Yahoo/Zacks.com
Emergent BioSolutions
BioThrax
orphan drugs
anthrax
vaccines
Flag link:
3 Biotech Stocks Spiking on Big Volume
3 Biotech Stocks Spiking on Big Volume
TheStreet.com
InterMune
Aegerion
Emergent BioSolutions
Flag link:
3 Biotechs Getting Plenty Of Attention From Investors
3 Biotechs Getting Plenty Of Attention From Investors
Seeking Alpha
Depomed
Rexahn
Cambia
Zipsor
Gralise
Cangene
Emergent BioSolutions
Flag link:
Emergent BioSolutions Earnings: Everything You Must Know Now
Emergent BioSolutions Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
earnings
Emergent BioSolutions
Flag link:
Positive Data from Emergent's BioThrax
Positive Data from Emergent's BioThrax
Yahoo/Zacks
BioThrax
Emergent BioSolutions
vaccines
anthrax
Flag link:
Emergent BioSolutions' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Emergent BioSolutions' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha
Emergent BioSolutions
earnings
Flag link:

Pages